PortfoliosLab logoPortfoliosLab logo
GDRX vs. ASPN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GDRX vs. ASPN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GoodRx Holdings, Inc. (GDRX) and Aspen Aerogels, Inc. (ASPN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GDRX achieves a -5.17% return, which is significantly lower than ASPN's 125.09% return.


GDRX

1D
-3.38%
1M
-3.02%
YTD
-5.17%
6M
-5.17%
1Y
-44.13%
3Y*
-22.21%
5Y*
-41.72%
10Y*

ASPN

1D
0.79%
1M
10.02%
YTD
125.09%
6M
118.90%
1Y
10.02%
3Y*
-3.23%
5Y*
-23.74%
10Y*
2.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GDRX vs. ASPN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
GDRX
GoodRx Holdings, Inc.
-5.17%-41.72%-30.60%43.78%-85.74%-18.99%-12.30%
ASPN
Aspen Aerogels, Inc.
125.09%-76.18%-24.71%33.84%-76.32%198.32%60.33%

Correlation

The correlation between GDRX and ASPN is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Sep 23, 2020

0.32

Fundamentals

Market Cap

GDRX:

$877.46M

ASPN:

$527.07M

EPS

GDRX:

$0.09

ASPN:

-$1.36

PS Ratio

GDRX:

1.13

ASPN:

2.28

PB Ratio

GDRX:

1.41

ASPN:

2.47

Total Revenue (TTM)

GDRX:

$787.89M

ASPN:

$230.26M

Gross Profit (TTM)

GDRX:

$638.38M

ASPN:

$27.46M

EBITDA (TTM)

GDRX:

$153.80M

ASPN:

-$59.70M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GDRX vs. ASPN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GDRX
GDRX Risk / Return Rank: 1717
Overall Rank
GDRX Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
GDRX Sortino Ratio Rank: 1717
Sortino Ratio Rank
GDRX Omega Ratio Rank: 1717
Omega Ratio Rank
GDRX Calmar Ratio Rank: 1616
Calmar Ratio Rank
GDRX Martin Ratio Rank: 1919
Martin Ratio Rank

ASPN
ASPN Risk / Return Rank: 4848
Overall Rank
ASPN Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
ASPN Sortino Ratio Rank: 5151
Sortino Ratio Rank
ASPN Omega Ratio Rank: 5555
Omega Ratio Rank
ASPN Calmar Ratio Rank: 4545
Calmar Ratio Rank
ASPN Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GDRX vs. ASPN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GoodRx Holdings, Inc. (GDRX) and Aspen Aerogels, Inc. (ASPN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GDRXASPNDifference
Sharpe ratioReturn per unit of total volatility

-0.71

Sortino ratioReturn per unit of downside risk

-1.51

Omega ratioGain probability vs. loss probability

0.92

1.13

-0.21

Calmar ratioReturn relative to maximum drawdown

-0.70

0.14

-0.84

Martin ratioReturn relative to average drawdown

-1.06

0.22

-1.28

GDRX vs. ASPN - Sharpe Ratio Comparison

The current GDRX Sharpe Ratio is -0.60, which is lower than the ASPN Sharpe Ratio of 0.11. The chart below compares the historical Sharpe Ratios of GDRX and ASPN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GDRX vs. ASPN - Drawdown Comparison

The maximum GDRX drawdown since its inception was -96.73%, roughly equal to the maximum ASPN drawdown of -95.96%. Use the drawdown chart below to compare losses from any high point for GDRX and ASPN.


Loading charts...

Drawdown Indicators


GDRXASPNDifference

Max Drawdown

Largest peak-to-trough decline

-96.73%

-95.96%

-0.77%

Max Drawdown (1Y)

Largest decline over 1 year

-63.48%

-70.86%

+7.38%

Max Drawdown (3Y)

Largest decline over 3 years

-79.76%

-91.90%

+12.14%

Max Drawdown (5Y)

Largest decline over 5 years

-96.03%

-95.96%

-0.07%

Max Drawdown (10Y)

Largest decline over 10 years

-95.96%

Current Drawdown

Current decline from peak

-95.50%

-89.99%

-5.51%

Average Drawdown

Average peak-to-trough decline

-75.04%

-56.50%

-18.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

41.64%

45.65%

-4.01%

Volatility

GDRX vs. ASPN - Volatility Comparison

The current volatility for GoodRx Holdings, Inc. (GDRX) is 16.31%, while Aspen Aerogels, Inc. (ASPN) has a volatility of 19.67%. This indicates that GDRX experiences smaller price fluctuations and is considered to be less risky than ASPN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GDRXASPNDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.31%

19.67%

-3.36%

Volatility (6M)

Calculated over the trailing 6-month period

46.65%

65.65%

-19.00%

Volatility (1Y)

Calculated over the trailing 1-year period

73.71%

92.76%

-19.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.03%

88.01%

-14.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

72.41%

74.97%

-2.56%

Dividends

GDRX vs. ASPN - Dividend Comparison

Neither GDRX nor ASPN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

GDRX vs. ASPN - Financials Comparison

This section allows you to compare key financial metrics between GoodRx Holdings, Inc. and Aspen Aerogels, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


50.00M100.00M150.00M200.00M20222023202420252026
194.01M
37.88M
(GDRX) Total Revenue
(ASPN) Total Revenue
Values in USD except per share items

GDRX vs. ASPN - Profitability Comparison

The chart below illustrates the profitability comparison between GoodRx Holdings, Inc. and Aspen Aerogels, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-50.0%0.0%50.0%100.0%20222023202420252026
89.6%
11.3%
Portfolio components
GDRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GoodRx Holdings, Inc. reported a gross profit of 173.85M and revenue of 194.01M. Therefore, the gross margin over that period was 89.6%.

ASPN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported a gross profit of 4.28M and revenue of 37.88M. Therefore, the gross margin over that period was 11.3%.

GDRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GoodRx Holdings, Inc. reported an operating income of 14.01M and revenue of 194.01M, resulting in an operating margin of 7.2%.

ASPN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported an operating income of -20.83M and revenue of 37.88M, resulting in an operating margin of -55.0%.

GDRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GoodRx Holdings, Inc. reported a net income of 10.11M and revenue of 194.01M, resulting in a net margin of 5.2%.

ASPN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported a net income of -23.69M and revenue of 37.88M, resulting in a net margin of -62.5%.


Frequently Asked Questions


GDRX and ASPN have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASPN has higher volatility (19.67%) compared to GDRX (16.31%). In terms of maximum drawdown, GDRX dropped -96.73% vs ASPN's -95.96%.

ASPN currently has the higher Sharpe Ratio (0.11 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GDRX and ASPN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer